At the same time as researchers seek for biomarkers to predict ketamine response, clinicians come across on their own with a conundrum: Which patients need to start with IV ketamine, and which with Spravato? And exactly how do The 2 compare head to head in precise response to treatment? The https://allann777jxl5.wikiconversation.com/user